Products for Research Use Only
RegisterLogin

Erlotinib-d8

CAT: 0804-HY-50896S3Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-50896S3Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Erlotinib-d8 (CP-358774-d8) is deuterium labeled Erlotinib. Erlotinib (CP-358774) is a directly acting EGFR tyrosine kinase inhibitor, with an IC50 of 2 nM for human EGFR. Erlotinib reduces EGFR autophosphorylation in intact tumor cells with an IC50 of 20 nM. Erlotinib is used for the treatment of non-small cell lung cancer[1]. Erlotinib is a click chemistry reagent, itcontains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
CAS Number
1266656-97-6
Product Name Alternative
CP-358774-d8; NSC 718781-d8; OSI-774-d8
UNSPSC
12352005
Target
Isotope-Labeled Compounds
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
COC([2H])([2H])C([2H])([2H])OC(C(OC([2H])([2H])C([2H])([2H])OC)=C1)=CC2=C1C(NC3=CC(C#C)=CC=C3)=NC=N2
Molecular Formula
C22H15D8N3O4
Molecular Weight
401.49
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Related Products

CatalogName
HY-50896-01Erlotinib
HY-50896S2Erlotinib-d4
HY-50896S1Erlotinib-13C6
HY-50896R-01Erlotinib (Standard)
HY-13256A-01Desmethyl Erlotinib
HY-12008-01Erlotinib (Hydrochloride)
HY-50896S-01Erlotinib-d6
HY-12008AErlotinib (mesylate)
HY-W002950-01Erlotinib lactam impurity
HY-13256ARDesmethyl Erlotinib (Standard)

Alternative Products

CatalogName
abx182439Erlotinib-D8 Hcl
A3397-5000Erlotinib
A8234-5000Erlotinib Hydrochloride
CS-EO-02363Erlotinib D4
BE164419-01Erlotinib base

Popular Products